GlycoActive™ HMOs,
suitable for all
We deliver bioactives for every stage of life, whether you’re building a product for newborns, athletes, aging population, or furry friends
Whether you're launching new SKUs or switching suppliers, Inbiose delivers high-purity HMOs with unmatched cost-effiency, flexible MOQs, and leading industry-leading innovation.
Human Milk Oligosaccharides (HMOs) are complex, non-digestible carbohydrates found naturally in breast milk. After lactose and lipids, they are the third most abundant solid component, with over 200 unique structures identified to date.
HMOs act as bioactive prebiotics, designed by nature to support gut health, immune function, and microbial balance, without being digested by the human body itself.
Our Human Milk Oligosaccharides (HMOs) mimic the complex sugars in human breastmilk — shown to support immunity, gut microbiota, and metabolic health in infants, adults and animals.
Our Human Milk Oligosaccharides (HMOs) mimic the complex sugars in human breastmilk — shown to support immunity, gut microbiota, and metabolic health in infants, adults and animals.
Nature's blueprint for gut, immune & metabolic health: now scalable for food, supplements and animal feed.
Most abundant HMOs in breast milk
Act as precision prebiotics and support gut barrier function
Highly present in animal milk
Key modulators of immune signaling & neurodevelopment
High concentration found in human milk
Structurally foundational for many other HMOs
HMOs are complex carbohydrates found in breast milk, evolved not to nourish, but to shape health in more profound ways.
HMOs fuel beneficial bacteria while crowding out unwanted microbes. Certain HMOs are known to support keys strains of Bifidobacteria, Akkermansia and other beneficial species.
HMOs guide the immune system with precision. By influencing immune signaling, they promote balance: enhancing defense without overreaction.
HMOs help reinforce the gut barrier, supporting digestive integrity and resilience, building a solid foundation for health across life stages.
HMOs support infant cognitive development, metabolic wellness, joint mobility, infection resilience, and even stress tolerance.
Human Milk Oligosaccharides (HMOs) are complex carbohydrates naturally found in breast milk. HMOs are the third most abudant solid ingredient in breast milk, following lactose and lipids. Although barely absorbed, and not digested by the infant, HMOs reach the colon intact. They nourish beneficial gut bacteria and block harmful microbes, and support the developing immune system. Research shows that HMOs also contribute to gut barrier function and early cognitive development, making them essential to infant health.
Absolutely. HMOs are highly versatile and can be used in sport drinks, yoghurts, infant formula, gummies, sachets, bars, capsules, and more. They offer a mild sweet taste and high heat stability, making them ideal for product innovation. Regulatory status and labeling requirements vary by region, so it’s best to consult our experts for tailored guidance.
Yes, HMOs are increasingly researched and formulated for adults, pets, livestock, and broader populations. While inspired by breast milk, specific HMOs can support gut health, immune regulation, and metabolic balance across age groups. Clinical and internal studies confirm their excellent safety profile, consistent with the fact that newborns naturally consume large quantities of HMOs.
HMOs are produced without using breast milk. Scientists design safe bacteria—similar to those used for making vitamins or enzymes—to ferment and create HMOs. Once fermentation is complete, the mixture is purified to remove the bacteria, yielding a clean, high-purity HMO that’s chemically identical to those found in breast milk. The result is safe, scalable, and ready for food and health applications.
While pregnant, women already start producing HMOs as early as the first trimester. There is great variability in quantity of individual HMOs that is produced in different women, and throughout the lactation period. One of the major differences is determined by genetics in the FUT2 gene: secretor vs non-secretor of 2'-FL.
Graph adapted from
Liu et al., 2023
Graph adapted from
Liu et al., 2023
Graph representing a non-secretor group (12%) from a US cohort, adapted from Plows et al., 2021